For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist ...

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

GLP-1: Glucagon-like peptide-1; RA: receptor agonist ... and will be crucial to making a final assessment of where these medications fit into our algorithm for effectively managing Type 2 diabetes.

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly ...

LLY's shares slip more than 6% as it cuts outlook for 2024 sales. Preliminary fourth-quarter revenues fall short of estimates ...

Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

Cardinal Health said on Tuesday it expects annual profit to be at the higher end of its previous forecast range, primarily ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...